August 30, 2012—Health Resources and Services Administration (HRSA) program integrity audits of two hospitals’ 340B drug discount programs identified no occurrences of drug diversion to ineligible patients, duplicate discounts under Medicaid, or eligibility issues, the Drug Discount Monitor has learned.
Denver Health and Hospital Authority, an integrated public health system which operates one of Colorado’s largest disproportionate share hospitals, and Fort Logan Hospital, a 25-bed critical access hospital in central Kentucky, received their audit results from HRSA in August, officials at both institutions confirm.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)